推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 有人說(shuō)中藥材這個(gè)行業(yè)2015年將迎來(lái)“柳暗花明”，因?yàn)楣墒械男星榻谳^好，大盤不斷上漲，多多少少直接或間接的有點(diǎn)關(guān)系。此言是按照過(guò)往經(jīng)驗(yàn)的推理所說(shuō)，中藥材的銷售好轉(zhuǎn)好像指初級(jí)原材料的銷售情況，如果是這樣，那么，就一定是終端銷售在擴(kuò)大，從而帶動(dòng)原材料的需求上升。
大家都知道經(jīng)過(guò)前幾年藥材的普漲，藥農(nóng)種植藥材的情緒非常高，造成了原料的連年積壓，這已是不爭(zhēng)的事實(shí)，即使終端銷售在不斷擴(kuò)大，但也不會(huì)很快消化還在增加的大量庫(kù)存。如果真能變?yōu)楝F(xiàn)實(shí)豈不是皆大歡喜，否則，也只能成為昨天的故事，藥商的笑料；或者說(shuō)，是為自已壯膽或給別人畫餅充饑。
整體藥市不景氣，也不能證明個(gè)別品種沒(méi)有活力。滋補(bǔ)類藥食兩用品種出盡了風(fēng)頭，大有獨(dú)上高樓之風(fēng)姿，阿膠、龜板膠、鹿角膠、枸杞、瑪卡等，它們隨時(shí)都在漲價(jià)，活血、補(bǔ)氣，強(qiáng)壯身心，有錢人多了去了，他們不在乎在自已身上花點(diǎn)小錢。還有，為了答謝別人之情，拿出手就是兩斤瑪卡幾斤西洋參，很大方的幾千元上去，這種情況很是正常，看看他們的售貨攤位和精美禮品包裝的銷售，你就會(huì)感到銷量的大小。隨著人們生活條件的提高，這些品種的銷量還會(huì)呈上升趨勢(shì)。
現(xiàn)在的中藥材市場(chǎng)好品種特別難求，大家更應(yīng)該把好分寸，因勢(shì)利導(dǎo)、以靜制動(dòng)，到底2015年中藥材行業(yè)能否“柳暗花明”？建議大家還是要事先做好充分的思想準(zhǔn)備。
